MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

Search

Odonate Therapeutics Inc

Chiusa

0

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

Massimo

Metriche Chiave

By Trading Economics

Odonate Therapeutics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 lug 2025, 15:29 UTC

I principali Market Mover

Mustang Bio Shares Jump After Orphan Drug Designation for Cancer Treatment

7 lug 2025, 23:44 UTC

Discorsi di Mercato

Nikkei May Fall on U.S. Tariff Concerns -- Market Talk

7 lug 2025, 23:44 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

7 lug 2025, 23:41 UTC

Discorsi di Mercato

Gold Edges Lower Amid Hopes for Possible Trade Agreements -- Market Talk

7 lug 2025, 23:19 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

7 lug 2025, 23:19 UTC

Discorsi di Mercato

AML3D Bull Sees Navy Letter Lowering Risks -- Market Talk

7 lug 2025, 22:20 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

7 lug 2025, 22:20 UTC

Discorsi di Mercato

AT&T's Fiber Strategy Positions Stock to Outperform -- Market Talk

7 lug 2025, 21:34 UTC

Acquisizioni, Fusioni, Takeovers

BlackRock's Latest Acquisition Is a Commercial Real Estate Bet -- Barrons.com

7 lug 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

7 lug 2025, 20:45 UTC

Acquisizioni, Fusioni, Takeovers

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7 lug 2025, 20:16 UTC

Discorsi di Mercato

Canada Bonds Set to Benefit From Rotation Away U.S. Assets -- Market Talk

7 lug 2025, 19:37 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Hold Their Ground -- Market Talk

7 lug 2025, 19:12 UTC

Discorsi di Mercato

Oil Futures Shrug Off Bigger OPEC+ Output Increase -- Market Talk

7 lug 2025, 18:33 UTC

Discorsi di Mercato

Gold Flat as Investors Assess Market Direction -- Market Talk

7 lug 2025, 18:27 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

7 lug 2025, 16:53 UTC

Utili

Freight Stocks Have a Tariff Overhang. Morgan Stanley Says It Could Be Worse. -- Barrons.com

7 lug 2025, 16:30 UTC

Discorsi di Mercato

Higher Prices Limit Power Sector's Natural Gas Use -- Market Talk

7 lug 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

7 lug 2025, 16:05 UTC

Acquisizioni, Fusioni, Takeovers

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7 lug 2025, 15:41 UTC

Discorsi di Mercato

Gold Futures Fall as Stronger U.S. Dollar Undermines Safe-Haven Demand -- Market Talk

7 lug 2025, 15:41 UTC

Discorsi di Mercato

Market Talk Roundup: Latest on U.S. Politics

7 lug 2025, 15:40 UTC

Discorsi di Mercato

Base Metal Prices Tick Lower on U.S. Dollar Strength -- Market Talk

7 lug 2025, 15:30 UTC

Discorsi di Mercato

Physical Oil Market Stable But Structural Weakness Looms -- Market Talk

7 lug 2025, 15:18 UTC

Discorsi di Mercato

BNP Cuts Brent Forecast on U.S. Shale, Iran Supply Resilience -- Market Talk

7 lug 2025, 15:14 UTC

Acquisizioni, Fusioni, Takeovers

MicroStrategy Goes a Week Without Buying Bitcoin. Saylor Has Advice for Crypto Traders. -- Barrons.com

7 lug 2025, 15:00 UTC

Acquisizioni, Fusioni, Takeovers

GSK Completes Acquisition of Efimosfermin

7 lug 2025, 14:52 UTC

Discorsi di Mercato

Dollar Faces Downward Pressures Stemming from Tariffs -- Market Talk

7 lug 2025, 14:51 UTC

Discorsi di Mercato

Bullish Factors Lift Oil Despite Downward Pressure -- Market Talk

7 lug 2025, 14:45 UTC

Discorsi di Mercato

Saudi Arabia Not Seeking to Take Oil Market Share -- Market Talk

Confronto tra pari

Modifica del prezzo

Odonate Therapeutics Inc Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

EBITDA

Utile operativo

$

Chi Siamo Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.